Costly sickle cell treatments raise challenges for Medicaid

Across the U.S., policymakers, government officials, and patients are uncertain how Medicaid will cope with the added budget strain.

January 29, 2024 Check out STAT+

Sponsored By

Illustration: Christine Kao/STAT; Courtesy: Kourtney Cunningham STAT+ | Pricey sickle cell treatments raise daunting new challenges for Medicaid programs Across the U.S., policymakers, government officials, and patients are uncertain how Medicaid will cope with the added budget strain. By Ed Silverman Scientists document first-ever transmitted Alzheimer's cases, tied to no-longer-used medical procedure Five Alzheimer's cases were tied to a growth hormone treatment that was once used for various causes of short stature but is no longer used. By Andrew Joseph Supreme Court slates abortion pill case for March The Supreme Court will hear arguments about access to the abortion pill mifepristone on March 26, it said Monday. By Sarah Owermohle AP Opinion: I'm an anesthesiologist. Kenneth Smith's execution by nitrogen gas was far from 'textbook' An anesthesiologist and expert on capital punishment writes that Kenneth Smith's execution by nitrogen gas tells us nothing. By Joel B. Zivot Can the government ask social media sites to take down Covid misinformation? SCOTUS will weigh in The court will consider whether the government's requests for sites to moderate Covid misinformation violated users' First Amendment rights. By Sarah Owermohle STAT+ | Cognito raises $35 million for Alzheimer's treatment device, touts benefits compared to drugs Instead of drugs, Cognito treats Alzheimer's with a headset utilizing sound and gamma frequency light. Trials are expected to close in 2025. By Mario Aguilar Francesca Jones for STAT STAT+ | From a small town in Wales, a scientific sleuth has shaken Dana-Farber — and elevated the issue of research integrity Harvard-affiliated Dana-Farber says it plans to retract six of the papers scientist Sholto David flagged and correct 31 of them. By Andrew Joseph

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Daily Recap? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2024, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser